Cover Image
市場調查報告書

肌肉侵犯型膀胱癌 (MIBC) :全球臨床實驗趨勢

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 329072
出版日期 內容資訊 英文 69 Pages
訂單完成後即時交付
價格
Back to Top
肌肉侵犯型膀胱癌 (MIBC) :全球臨床實驗趨勢 Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月27日 內容資訊: 英文 69 Pages
簡介

本報告提供全球肌肉侵犯型膀胱癌 (MIBC) 治療藥臨床實驗相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗等資料。

簡介

  • 肌肉侵犯型膀胱癌 (MIBC)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:腫瘤治療藥臨床實驗上肌肉侵犯型膀胱癌 (MIBC) 的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤治療藥臨床實驗上肌肉侵犯型膀胱癌 (MIBC) 的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

肌肉侵犯型膀胱癌 (MIBC) 治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Celldex Therapeutics, Inc.
    • Astellas Pharma Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Memorial Sloan Kettering Cancer Center
    • Fox Chase Cancer Center
    • Trans Tasman Radiation Oncology Group
    • Brown University
    • Centre Val d'Aurelle - Paul Lamarque
    • Nara Medical University
    • Hiroshima University Hospital
    • Hirosaki University
    • Sun Yat-sen University
    • Tata Memorial Hospital

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2600CTIDB

GlobalData's clinical trial report, "Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015" provides data on the Muscle Invasive Bladder Cancer (MIBC) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muscle Invasive Bladder Cancer (MIBC). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Muscle Invasive Bladder Cancer (MIBC)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Muscle Invasive Bladder Cancer (MIBC)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Celldex Therapeutics, Inc.
      • Clinical Trial Overview of Celldex Therapeutics, Inc.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Fox Chase Cancer Center
      • Clinical Trial Overview of Fox Chase Cancer Center
      • Trans Tasman Radiation Oncology Group
      • Clinical Trial Overview of Trans Tasman Radiation Oncology Group
      • Brown University
      • Clinical Trial Overview of Brown University
      • Centre Val d'Aurelle - Paul Lamarque
      • Clinical Trial Overview of Centre Val d'Aurelle - Paul Lamarque
      • Nara Medical University
      • Clinical Trial Overview of Nara Medical University
      • Hiroshima University Hospital
      • Clinical Trial Overview of Hiroshima University Hospital
      • Hirosaki University
      • Clinical Trial Overview of Hirosaki University
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Tata Memorial Hospital
      • Clinical Trial Overview of Tata Memorial Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Trans Tasman Radiation Oncology Group, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brown University, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nara Medical University, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hirosaki University, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tata Memorial Hospital, 2015*

List of Figures

  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top